Skip to main content
. 2018 Oct 9;8:15039. doi: 10.1038/s41598-018-33280-7

Figure 5.

Figure 5

A potential application of the ELV-SWATH-MS workflow as a multiplex biomarker screening assay. A panel of 20 biomarkers consisting of proteins related to urinary extracellular vesicles (a) and candidate urine biomarkers (b) was applied for targeted data extraction of ELVs, MVs and UP samples. Based on expression data in this panel, three ELV replicates were classified out of the MV and UP samples by unsupervised principal component analysis (left panel) and hierarchical clustering (right panel) (c). This result supported future development of multiplex biomarker screening assay as a part of quality control in urinary ELV isolation.